On our screens:Stocks with no debt
Is the price fair?
What PACS's price assumes
PACS Group, Inc. trades at 25.5× earnings against 19.6× for the median Medical Care Facilities name, more expensive than its own group.
25.5
Trailing P/E · Medical Care Facilities median 19.6 · 1.30× the median: the market pays up for this one
- Price / sales
- 0.96
Price / sales · as of 2026-Q1
- Free cash flow yield
- 7.1%
Free cash flow yield · Medical Care Facilities median 7.1%
- Growth the price implies
- +1.0%
Growth the price implies · What free cash flow would have to do every year for a decade to justify today's price, discounted at 9.0%.
Details›
- Price / book2026-Q1
- 5.02
- EV / EBIT2026-Q1
- 13.6
- EV / sales2026-Q1
- 0.96
- Healthcare median P/E362 names
- 29.9
- Medical Care Facilities median P/E29 names
- 19.6
- Free cash flow, trailing twelve months
- $456M
- Market capitalisation
- $6.44B
Multiples from SEC filings and end-of-day closes; implied growth from a reverse discounted cash flow. Group medians across the names Ryufin tracks.